JG
ANIP icon

Jefferies Group’s ANI Pharmaceuticals ANIP Stock Holding History

Jefferies Group’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-29,244
Closed -$1.7M – 2289
2018
Q1 		$1.7M Buy
+29,244
New +$1.86M 0.01% 938
2017
Q2 		– Sell
-4,925
Closed -$244K – 2155
2017
Q1 		$244K Buy
+4,925
New +$277K ﹤0.01% 1927
2015
Q3 		– Sell
-11
Closed -$1K – 2262
2015
Q2 		$1K Buy
+11
New +$655 ﹤0.01% 3191

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Jefferies Group's ANIP Position: Q2 2018 in Review

Jefferies Group sold out of ANI Pharmaceuticals (ANIP) in Q2 2018, closing a stake of 29,244 shares — an estimated $1.7M sold.

Jefferies Group first reported a position in ANIP in Q2 2015 and held it in 3 quarters. The position peaked at $1.7M in Q1 2018. 184 funds tracked by Wall St. Rank hold ANIP as of Q2 2018.

  • Jefferies Group reported no remaining ANI Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Jefferies Group sold 29,244 ANI Pharmaceuticals shares in Q2 2018, an estimated $1.7M.
  • Jefferies Group first reported a position in ANI Pharmaceuticals in Q2 2015 and held it in 3 quarters.
  • Jefferies Group's ANI Pharmaceuticals position peaked at $1.7M in Q1 2018.
  • 184 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2018.

Based on Jefferies Group's 13F filing for Q2 2018, filed 14 Aug 2018.